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Introduction
Primary melanocytic neoplasms of  the meninges (menin-
geal melanocytomas) are uncommon neoplasms of  the cen-
tral nervous system; only 23 cases have been published up 
to now (1-14; Table 1). These neoplasms may occur in a 
diffuse or localized form (15, 16). Contrary to metastases 
from malignant skin melanoma, primary melanocytic le-
sions are very rare, with an incidence of  1 per 10 million 
for melanocytomas and 0.5 cases per 10 million for primary 
malignant melanomas (17). They usually have an intracra-
nial localization but also involve the spinal column, where 
they are most often detected intradurally and extrame-
durally (5, 18-24). 
This tumor entity was first described as meningeal mela-
nocytoma by Limas and Tio in 1972 (25). Diffuse entities 
such as melanocytosis and the highly malignant melanoma-
tosis generally occur in the setting of  dermatologic syn-
dromes—for example, neurocutaneous melanosis and ne-
vus of  Ota (26-28). Localized tumors present as leptomen-
ingeal masses and range from well-differentiated melanocy-
tomas to lesions of  intermediate malignancy and overtly 
malignant melanomas (29). According to the World Health 
Organisation (WHO) classification of  primary brain tu-
mors, meningeal melanocytomas belong to the subgroup of 
primary melanocytic lesions (15, 30). Based on a proposi-
tion by Brat et al. (29), the WHO classification assigns an 
intermediate grade to melanocytomas with increased mi-
totic activity and infiltrative growth that fail to meet all 
characteristics of  malignant melanoma (15).
Melanocytomas are derived from scattered melanocytes 
that are present in the leptomeninges, primarily at the base 
of  the brain, in the posterior fossa, and around the upper 
cervical spinal cord. In cases with an intraparenchymal 
localization, the melanocytes most probably originate from 
the Virchow-Robin spaces (2). Melanocytomas are com-
monly solitary, low-grade neoplasms that do not invade 
surrounding structures (15). They are usually characterized 
by a benign clinical course, but local recurrence may occur 
(7, 31). 
Intermediate-grade lesions show histological features 
suggestive of  aggressive behavior such as increased mitotic 
activity and/or invasion of  the CNS, but lack the overt 
cytological atypia of  melanomas (15, 29).
Although the terminologies introduced in the literature 
suggest a clear dichotomy between low-grade melanocy-
toma and high-grade melanoma, their differentiation is 
neither absolute nor clearly defined in published cases. Ap-
propriate descriptions and the nosology of  lesions along 
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Authors, year (ref) Age Sex Location Resection 
(macro-
scopic)
Followup 
(months)
Recur-
rence
Radio-
therapy
Comment
Barth et al.  1993 
(1)
49 F T10-T12 subtotal 48 yes no patient died after CSF seeding 
Glick et al. 1997 
[2]
69 M C1-C2 total 60 no no
39 F T8-T9 subtotal 12 no yes
27 F T1-T6 total 24 yes no
56 F T12 total 48 no no
74 F T11-T12 total 12 no no re-resection
70 M C1 total no followup -- -- patient died 10 days after sur-
gery
24 F T12-L1 total 24 no no re-resection
Delhaye et al. 
2001 [3]
38 F T6-T9 subtotal 48 yes no patient died after CSF seeding 
Iida et al. 2002 [4] 42 M T10 not de-
scribed
4 no no patient died 4 months after 
surgery: urinary infection
Turhan et al. 2004 
[5]
19 F T8 total 36 no no
Van Paesschen et 
al. 2004 [6]
51 M C1-C2 total no followup -- --
Horn et al. 2008 
[7]
37 F C1-C3 total 38 yes no
37 F T9-T10 total 16 yes no
48 M T12 total 185 yes no
Chacko et al. 
2008 [8]
22 M T6-T11 total 96 no no
Karikari et al. 
2009 [9]
32 F T10 total 3 no no
20 M T12 total 2 no no
Caruso et al. 2009 
[10]
62 M T11-T12 total 24 no no
Perrini et al. 2010 
[11]
79 F T10-T11 subtotal 30 yes no re-resection; malignant trans-
formation
Eskandari et al. 
2010 [12]
45 M T11 subtotal 36 yes yes
Muthappan et al. 
2012 [13]
61 F C3-C4 total 36 no nos
Kahilogullari 
2012 [14]
28 F T total no followup -- --
Present report 
2014
63 M C2-C3 total 18 yes yes
that spectrum are still not transparent, especially for inter-
mediate tumors between the two extremes (intermediate-
grade melanocytomas).
The differential diagnosis of  melanocytomas includes 
primary or metastatic malignant melanoma (32, 33), mela-
notic schwannoma (34), melanotic meningioma (1, 2, 25, 
34-36), and melanoblastosis (37).  
Here we report a  rare case of  a cervical intramedullary 
melanocytoma of  intermediate grade. Our diagnosis was 
based on imaging, histomorphological criteria as described 
by Brat et al. (15, 29), and immunohistochemical staining.
Case report
 History and clinical presentation
A 63-year-old male patient was referred to our emer-
gency department with slight progressive weakness of  the 
right side of  his body for over one year and concomitant 
paraesthesia of  his right hand. On initial examination, the 
patient was in good general condition. We noticed a global 
weakness of  the muscles of  the right-side upper and lower 
limbs (strength grade 3/5 according to the Medical Re-
search Council scale). Tendon reflexes were preserved. Par-
ticularly striking was a bilateral positive Babinski sign. His 
neurological status was otherwise unremarkable. Secondary 
diagnoses comprised pulmonary fibrosis with respiratory 
partial insufficiency, pulmonary hypertension, and diabetes 
mellitus. Pulmonary embolism was noted in the patient's 
medical history seven years ago. 
Fig. 1. The sagittal T1- (A) and T2-weighted (B) images and 
the postcontrast sagittal (C) and axial (D) fat-suppressed 
T1-weighted images clearly show the intramedullary, para-
central right located, expansive melanocytoma at the C2 / 
C3 level with homogeneous contrast enhancement. Addi-
tionally, a T2w hyperintense (B) per focal tumoral edema 
was noticed, suggestive of myelopathy.
Due to the overt muscle weakness, MR imaging of  the 
entire spinal canal was performed under suspicion for a 
pathology of  the upper cervical spine, for example, disc 
herniation, spinal canal stenosis, or a cervical 
polyradiculopathy. 
Preoperative imaging
Spinal MRI included precontrast sagittal and axial T1- 
and T2-weighted images, a sagittal T2-gradient echo se-
quence (GRE), sagittal diffusion-weighted imaging (DWI), 
and T2-weighted 3D space; after contrast application, sag-
ittal and axial fat-suppressed T1-weighted images were 
acquired. The initial MRI examination indicated an in-
tramedullary, paracentral right located, T1w hyper- and 
T2w-isointense, expansive tumorous lesion at the level of  
the second and third cervical vertebrae (Fig. 1, A-D). The 
solitary, solid, enhancing mass showed an axial expansion 
of  11 x 13 mm and measured 16 mm in craniocaudal ex-
tent. The neoplasm was not diffusion restricted, and there 
were no associated susceptibility artifacts in the T2w-GRE. 
Additionally, a T2w-hyperintense per focal tumoral edema 
was noticed, suggestive of  myelopathy. No atrophy of  the 
cervical myelon was observed.  
Differential diagnosis encompassed i) ependymoma,  ii) 
astrocytoma iii) melanotic meningioma, and iv) melanotic 
schwannoma. 
Operation report
The patient underwent microsurgical operation with the 
purpose of  complete tumor resection. Under sonographic 
and constant electrophysiologic intraoperative monitoring, 
a C2 and C3 hemi-laminectomy was performed, and the 
dura was opened longitudinally. A bulge was noted ventral 
to the C2 and the C3 dorsal nerve rootlets on the right 
side, with enlargement of  the swollen spinal cord. Through 
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Fig. 2. Intraoperative view of 
the spinal cord after opening 
the dura mater via dorsal lami-
nectomy; the tumor shines 
brightly in (A). Melanocytoma 
with visible caudal tumor edge 
(B) and partially dissected 
melanocytoma (C).
a small tumor nodule protruding between the right dorsal 
nerves C2 and C3, the pia mater was prepared to enable 
access to the intramedullary tumor mass (Figs. 2, A-C). 
With the operating microscope under high magnification, it 
was possible to dissolve the soft parts of  the tumor and to 
separate the tumor mass from the spinal cord. The tumor 
almost covered the entire circumference of  the spinal cord 
and could be removed. Laterally, the tumor mass was firmly 
adherent to the two dorsal nerve roots C2 and C3. This 
part of  the tumor mass was sharply dissected and removed.  
At the end of  the operation, there was no macroscopic evi-
dence of  a residual tumor. Hemostasis was achieved, and a 
watertight dural closure was performed. During the entire 
operation, the potentials of  the electrophysiological moni-
toring remained stable. 
Histopathology
Histopathological examination revealed a spindle-cell 
neoplasm with melanin pigmentation, moderate mitotic 
activity (4 mitoses/10 high-power fields; MIB1 overall 5%, 
focally up to 8%), positivity for melanocytic markers by 
immunohistochemistry (S100 protein, Melan A, HMB-45), 
and infiltrative growth pattern (Figs. 3A-F). The tumor cells 
did not express GFAP, EMA, CD34, DOG1, CD117, 
broad-spectrum cytokeratins, desmin, smooth-muscle actin, 
CD99, synaptophysin, or chromogranin. 
Whole body PET-CT, gastroscopy/colonoscopy, and a 
dermatologic consultation (including retina and tympanic 
membrane screening) excluded a peripherally located pri-
mary malignant melanoma or metastases. In summary, a 
primary intramedullary cervical melanocytoma was diag-
nosed. An intermediate grade was assigned due to the 
moderate mitotic activity and infiltrative growth pattern, 
without significant cytological atypia or necroses (15, 29).
Postoperative evaluation and followup 
The patient quickly regained motor function in the mus-
cles of  the upper and lower limb (postoperative strength 
grade 4/5, according to the Medical Research Council 
scale). The concomitant paraesthesia of  his right hand im-
proved in the postoperative followup.
The immediate postoperative native and postcontrast 
MRI scans of  the spine confirmed the total tumor resec-
tion; the signs of  cervical myelopathy were still recogniz-
able, although not as marked as before the operational in-
tervention. 
There was no evidence of  a peripherally located primary 
malignant melanoma or metastases by whole body PET-
CT, gastroscopy, colonoscopy, and dermatologic examina-
tion (including retina and tympanic membrane 
screening). For monitoring of  the patient, clinical exams 
and serial MRIs were performed every 3 months. The first 
followup MRI revealed a solid enhancing tumor nodule at 
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Fig. 3. Histological examination revealed a melanocytic neoplasm with moderate mitotic activity and infiltrative growth 
pattern. Conventional hematoxilin and eosin staining (A; x100) shows lack of substantial cytologic atypia; a mitotic figure 
is depicted in the inset. Moderate MIB1 staining supports higher proliferative potential (B; x400). Melanocytic differentia-
tion is disclosed by melanin pigmentation (C; Fontana-Masson staining, x400), and immunohistochemical positivity for 
the melanocytic markers HMB45 (D; x400) and Melan A (E; x200). Staining for glial fibrillary acidic protein (F; GFAP, 
x100) highlights the invasive tumor growth pattern, with unstained tumor cells and positively stained infiltrated central 
nervous tissue. 
the right adherent lateral resection border (4 x 7 x 13 mm) 
following the same signal characteristics as the primary 
melanocytoma, in keeping with tumor recurrence (Figs. 4A-
D). Percutaneous stereotactic radiotherapy with a fraction 
of  5 x 1.8 Gy per week and a cumulative dose of  45 (linear 
accelerator, 6 MV photon beam) was initiated. Nine 
months after radiotherapy, the recurrent tumor nodule was 
unchanged in size and configuration, in native and postcon-
trast MRI. Eighteen months after surgical resection and 15 
months after radiation therapy, the patient remained neuro-
logically stable with intermittent slight weakness (strength 
grade 4/5, according to the Medical Research Council 
scale) of  the lower and upper right extremities. 
Discussion
Primary melanocytic tumors of  the spine are part of  a 
spectrum of  rare neoplasms derived from scattered mela-
nocytes located in the leptomeninges. These melanocytes 
are derived from the neural crest during early embryonic 
development and are most frequently encountered in the 
recesses of  the sulci at the base of  the brain and around the 
brain stem and upper part of  the cervical spinal cord (38). 
Up to now, the genetic alterations associated with these 
neoplasms are unknown (39).
Melanocytomas consist of  spindle-shaped cells with oval 
nuclei, small nucleoli, a nested growth pattern, and differ-
ent amounts of  melanin pigment. The existence of  amela-
notic subtypes is well established, rendering immunohisto-
chemical analysis even more crucial in firmly establishing 
melanocytic differentiation and excluding other and far 
more frequent low-grade spindle-cell tumors (meningioma, 
schwannoma, and paraganglioma). Melanocytomas are 
immunohistochemically positive for S100 protein and the 
more specific melanocytic markers HMB-45 and Melan A 
(MART-1). According to the WHO criteria, low-grade 
melanocytomas are cytologically bland, solitary neoplasms 
with inconspicuous mitotic activity (<1 Mitosis/10 HPF, 
MIB1 <1-2%). At the other end of  the spectrum, malig-
nant melanomas are frankly malignant, widely infiltrating 
neoplasms with overt cytological atypia, brisk mitotic activ-
ity, and necrosis. Grading of  tumors between those ex-
tremes is problematic, particularly due to their rarity. Ac-
cording to the WHO and based on a proposition by Brat et 
al., an intermediate-grade tumor comparable to our case is 
assigned to melanocytomas with increased mitotic activity 
that fail to meet all characteristics of  malignant melanoma 
(15, 29, 35, 40). This categorization means that they show 
some histological features suggestive of  aggressive behavior.  
Intraoperatively, surgeons usually encounter a localized 
soft, but solid pigmented mass with meningeal attachment 
(5, 7, 29). Contrary to the report of  Turhan et al. (5), who 
described a capsule delimiting the tumor, we did not ob-
serve any delineating peritumoral capsule; this was con-
firmed by the infiltrative pattern in the histology examina-
tion. As a consequence, the absence of  a characteristic tu-
mor capsule means that even macroscopically apparent 
total extirpation cannot exclude the possibility of  minimal 
residual tumor. Diagnosis at the time of  surgery is often 
difficult and misleading, as distinctive cell types are not 
obvious until histopathological analysis is completed.
Twenty-three cases (1-14, Table 1) of  spinal intramedul-
lary melanocytomas have been reported in the literature 
since 1993; we add a further case descriptions of  this rare 
tumor entity. We would like to point out that Iida et al. (4) 
reported two cases with spinal melanocytoma—one in-
tradural extramedullary located and the other intramedul-
lary manifested—and we review only the one case with the 
intramedullary tumor. 
Spinal melanocytic melanomas are more common in 
women, typically in the fourth decade (13), in keeping with 
in our review (14 female and 10 male). Our patient was 
male; his age was consistent with the patient population of  
45.5 years (range, 19 to 79 years). Similar to our case, all 
patients described a slowly progressive evolution of  clinical 
signs of  myelopathy or radiculopathy. The length of  the 
postoperative clinical and radiographic evaluation in 21 of  
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Fig. 4.The followup MRI after 3 months indicates the solid 
enhancing tumor recurrence (B) at the right adherent lat-
eral resection border at the C2 (C) and C3 level (D). The 
signs of cervical myelopathy were still recognizable on the 
sagittal T2-weighted (A) images.
these 24 (87.5%) patients varied from 2 months to 185 
months (average, 38 months). In two (8.3%) of  the reviewed 
cases, the postoperative course was not documented. One 
patient (4.2%) died 10 days after surgery, so no followup 
observation was possible.
On first MRI, the tumor mass was located central and 
intramedullary in the thoracic spine in 18 of  the 24 (75%) 
analyzed cases. In the remaining 6 patients (25%), the loca-
tion of  the intramedullary melanocytoma was cervical.
Local recurrence occurred In five of  the 21 (23.8%) cases 
with followup and documented macroscopic complete tu-
mor resection (2,7; current case), as well as in four patients 
(19%) with subtotal tumor extirpation (1, 3, 11 ,12), proba-
bly due to the persistence of  a very small (macroscopic or 
nonvisible) residue (2). We believe that there is another ex-
planation for the spectrum of  low-grade to intermediate-
grade melanocytomas determined by histopathological 
features, as described for melanocytic neoplasms elsewhere 
in the central nervous system (29). Perrini et al. graded their 
case as an intermediate-grade melanocytoma (11). A clear 
histological grading or description to distinguish low-grade 
from intermediate-grade neoplasms is lacking in most of  
the published cases. Taking into account the high recur-
rence rates of  the reviewed intramedullary melanocytomas, 
we conclude either that there is a higher rate of  
intermediate-grade melanocytomas in an intramedullary 
spinal localization compared to melanocytomas elsewhere 
in the central nervous system, or that histologically classi-
fied low-grade melanocytomas have a relevant potential for 
local recurrence.
Among the previously mentioned studies with total and 
subtotal tumor removal and recurrence in the followup, 
only two patients (9.5%) received adjuvant radiotherapy 
(12; current case). One patient (4.8%) with subtotal tumor 
surgery received adjuvant radiotherapy without local tumor 
recurrence (2). In summary, only 3 of  21 patients (14.3%) 
with intramedullary melanocytoma underwent adjuvant 
radiotherapy (2,12; current case). However, overall, 10 of  
21 patients (47.6%) had local tumor relapse, including our 
patient with local tumor recurrence at the 3-month fol-
lowup MRI.  In our current patient, the multidisciplinary 
tumour board committee decided to initiate percutaneous 
stereotactic radiotherapy. 
Thus, there is uncertainty whether immediate postopera-
tive radiotherapy would have prevented or delayed tumor 
recurrence, especially in patients with histologically verified 
intermediate-grade melanocytoma. 
Our literature review aims to support the fact that intra-
medullary melanocytoma lacks characteristic imaging fea-
tures. Typical MRI findings are that of  an intramedullary 
lesion iso- to hyperintense on T1-weighted sequences, hy-
pointense on T2-weighted sequences, and with homogene-
ous enhancement—in keeping with the MRI characteristics 
of  our patient (Fig. 1A-D). These signal features are biased 
by variable degrees of  tumor melanisation that affect the 
signal characteristics on MRI (9,41). 
Thus, nonspecific imaging characteristics, in addition to 
the rarity of  tumors in the intramedullary spinal cord, lead 
to their misdiagnosis and frequent exclusion from the dif-
ferential diagnosis. In the current patient, the axial MRI 
revealed a paracentral extension of  the tumor, unlike the 
more centrally localized lesions associated with ependy-
moma or astrocytoma. Hence, meningeal melanocytoma 
should be included in the differential diagnosis of  lesions 
that show a slight T1w hyperintensity and a paracentral 
component on MRI.
The aim of  the treatment should be complete tumor 
resection with preservation of  neurological function. In the 
past, local tumor control rates were four times higher if  
complete resection was achieved, and morbidity and mor-
tality rates for incomplete resection now mandate use of  
adjuvant radiation therapy (7, 42-45). The aggressive na-
ture of  intramedullary melanocytomas with frequent local 
recurrence has already been documented by Chacko and 
Rajshekhar (8), who observed what they referred to as “an 
infiltrative residue of  the spinal cord substance during in-
traoperative inspection of  the resection cavity of  the tumor 
at the cranial and caudal poles.” The exact tissue type in-
volved is still unknown, and although these authors advo-
cated a radical excision, they did not report aggressive re-
section of  the infiltrative portions from the spinal cord. 
Although their patient showed no radiographic recurrence 
at 8 years post-surgery, the infiltrative nature as well as ag-
gressive and seemingly inconsistent behavior of  this tumor 
type must— in our opinion—take into account intraopera-
tive and followup imaging.  
The risks of  recurrence or residual tumor progression 
are important, and several reports focus on possible lepto-
meningeal seeding even years after surgical resection (46-
48). Our review includes reports of  two patients who died 
of  subarachnoidial dissemination, both after a four-year 
course of  disease (1,9).   
In the present case, we decided to defer initial radiother-
apy. In the event of  early local recurrence after 3-month 
followup, we resolved to pursue adjuvant radiation, because 
operative re-resection is often associated with significant 
morbidity (13). Rades et al. (43) achieved a 80% five-year 
local disease control after complete resection, compared to 
100% with complete resection and radiotherapy. Interest-
ingly, Rades et al. (43) showed 72% disease control with 
radiotherapy compared to 8% after incomplete resection 
only (p <0.001). Although these tumors are slow-growing, 
they have a propensity to recur early (3-month-interval) 
and metastasize via the cerebrospinal fluid. Malignant 
transformation is described in the literature for some ex-
tramedullary cases (48-51) and one intramedullary melano-
cytoma (11). Therefore, Rades and Schild (44) proposed 
the routine use of  radiation in cases of  subtotal tumor re-
section and even after complete surgical extirpation; how-
ever, long-term clinical data are limited. In consequence, 
we also emphasize the importance of  very careful postop-
erative monitoring. Long-term monitoring is necessary to 
determine the outcomes of  spinal intramedullary melano-
cytomas after surgical resection and radiotherapy, to im-
prove our understanding of  these tumors, and to enable 
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improved treatment strategies with special regard to the 
treatment of  local tumor recurrence. 
The question still remains open whether more aggressive 
tumor treatment with early postoperative adjuvant therapy 
should be recommended for patients with locally aggressive 
tumors, especially in cases of  histopathologically deter-
mined intermediate-grade melanocytoma. 
Conclusions
Spinal melanocytomas are rare, especially when located 
in an intramedullary region, and are often not considered 
during differential diagnosis of  intramedullary spinal cord 
tumors. The lack of  distinctive imaging characteristics in-
creases the challenge during preoperative diagnosis. The 
high recurrence rate of  intermediate-grade intramedullary 
melanocytomas even after total tumor resection, and their 
histopathological features of  aggressive behavior (for exam-
ple, increased mitotic activity, infiltrative pattern) indicate 
close followup with serial MR imaging.
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